|Title:|| Dosage form for treating cardiovascular diseases|
|Abstract:||An osmotic device is disclosed comprising a first composition, and a second composition with the beneficial drug isradipine in the first composition.|
|Inventor(s):|| Ayer; Atul D. (Palo Alto, CA), Swanson; David R. (Palo Alto, CA), Kuczynski; Anthony L. (Palo Alto, CA) |
|Assignee:|| ALZA Corporation (Palo Alto, CA) |
1. A composition for use in an osmotic device, said composition comprising a polyethylene oxide comprising a molecular weight of about 7,000,000 to 7,800,000 and an osmotically
effective compound, and which composition when in use in an osmotic device is means for delivering a drug from the osmotic device over a prolonged period of time.